Showing results (991-1000 of 2,388) with videos related to
Sort By:
Pageof 239
Digestive Diseases (Basel, Switzerland)|November 23, 2011
Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when?Daniel C BaumgartDigestive Diseases (Basel, Switzerland)|November 19, 2011
Acid-NSAID/aspirin interaction in peptic ulcer diseaseRichard H Hunt, Yuhong YuanDigestive Diseases (Basel, Switzerland)|November 19, 2011
Long-term acid inhibition: benefits and harmsBojan TepešDigestive Diseases (Basel, Switzerland)|November 19, 2011
Complications of peptic ulcer diseaseTomica Milosavljevic, Mirjana Kostić-Milosavljević, Ivan Jovanović, et al.Digestive Diseases (Basel, Switzerland)|November 19, 2011
Role of acid suppression in the development and progression of dysplasia in patients with Barrett's esophagusF Kastelein, M C W Spaander, K Biermann, et al.Digestive Diseases (Basel, Switzerland)|November 19, 2011
No acid, no ulcer: Dragutin (Carl) Schwarz (1868-1917), the man ahead of his timeStella Fatović-Ferenčić, Marko BanićDigestive Diseases (Basel, Switzerland)|August 11, 2011
Molecular targeted therapy for hepatocellular carcinoma: bench to bedsideMasatoshi KudoDigestive Diseases (Basel, Switzerland)|August 11, 2011
Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stoneHwi Young Kim, Joong-Won ParkDigestive Diseases (Basel, Switzerland)|August 11, 2011
Future treatment option for hepatocellular carcinoma: a focus on brivanibMasatoshi KudoDigestive Diseases (Basel, Switzerland)|August 11, 2011
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.Pageof 239